Mandate

Vinge has represented Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB

Vinge has represented the leading infrastructure group Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB from Vestum. These companies are engaged in contracting activities within the construction sector. The total purchase price for the shares amounts to 747 MSEK. All key executives in the companies will become shareholders in Eleda.

Hanell Entreprenad i Gävle AB and FlexiRail AB both have extensive experience in railway maintenance, and Eleda also strengthens its leading position in ground construction in Stockholm through the acquisition of Marbit Aktiebolag.

The transaction is subject to regulatory approvals, and the closing is expected to occur in the first quarter of 2025.

Vinge's team primarily consisted of Christina Kokko, Johanna Wiberg, Eléonore Friberg, Madelene Andersson, and Chris Bastholm (M&A), Niclas Lindblom (Construction), Sara Franson (Real Estate), Hanna Kövamees (Commercial Agreements), Siri Bromberg (GDPR), Calle Tengwall Pagels and William Carlberg Johansson (Banking and Finance), Simon Söderholm and Jessica Jacob (Employment Law), Hayaat Ibrahim and Gulestan Ali (Compliance), Marcus Glader, Daniel Wendelsson, Dagne Sabockis, Lovisa Lewin, and Lovisa Arpi (Competition Law and FDI), and Jasmina Skandrani (Project Assistant).

Read the client's press release here.

Related

Vinge is advising Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of shares whereby Xspray receives issue proceeds of approximately SEK 135 million before deduction of transaction costs.
December 03, 2024

Vinge has advised Fortum in connection with the divestment of its recycling and waste business

Vinge, alongside among others Castrén & Snellman, has advised Fortum in connection with the divestment of its recycling and waste business to Summa Equity through its portfolio company NG Group. The debt free purchase price is approximately EUR 800 million.
December 02, 2024

Vinge advises Active Biotech in connection with rights issue

Vinge advises Active Biotech AB (publ) in connection with a rights issue of approximately SEK 43 million.
November 29, 2024